BIOLINERX     Print Page  Close Window

SEC filings
6-K
BIOLINERX LTD. filed this Form 6-K on 04/05/2017
Entire Document
 

 

 

If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between us.

 

  Very truly yours,
   
  BIOLINERX LTD.
     
  By: /s/ Philip A. Serlin
    Name:  Philip A. Serlin
    Title:  Chief Executive Officer

 

Confirmed as of the date first written above mentioned, on behalf of itself and as Representative of the several Underwriters named on Schedule 1 hereto:

 

JMP SECURITIES LLC

 

By: /s/ Andrew Mertz  
Name:  Andrew Mertz  
Title:  Managing Director  

 

 36